Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

CEM Contract Win

7th May 2026 07:00

RNS Number : 3160D
Light Science Tech. Holdings PLC
07 May 2026
 

Light Science Technologies Holdings plc

("LSTH", "Light Science", the "Company" or the "Group")

 

CEM Contract Win

 

New healthcare client aligned with strategy targeting higher margin revenue opportunities

 

Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business providing real-world solutions targeting issues including global food security and fire safety, announces that its Contract Electronics Manufacturing division ("CEM"), UK Circuits and Electronics Solutions Limited ("UKC"), has secured a new client in the healthcare devices sector.

 

The customer is a UK-headquartered, international healthcare manufacturer specialising in the design, production and supply of medical devices and consumables used across acute and community care settings. Its core product portfolio supports infection prevention, clinical waste management and surgical procedures, addressing critical, high-volume needs across healthcare systems globally.

 

The business has an established international footprint and a strong reputation for quality, reliability and regulatory compliance, supplying mission-critical products that are embedded within everyday clinical practice across hospitals and care environments worldwide.

 

The first order is valued at c. £160,000, with total annual orders from the customer potentially worth up c.£650,000 per annum going forward, subject to the contract proceeding as expected.

 

The CEM division continues to supply products to a growing number of customers across an increasingly broad range of market sectors, targeting long-term contracts that enhance revenue visibility. The Group remains focused on higher-margin opportunities while reducing exposure to individual markets and customers.

 

Simon Deacon, CEO of LSTH, commented: "We are delighted to have secured another contract win this week, further demonstrating the momentum building within the Group. We remain highly focused on converting the Group's pipeline and establishing long-term partnerships as we continue to re-position the CEM division into key high-margin growth markets including defence, medical and healthcare."

 

 

For additional information please contact:

 

Light Science Technologies Holdings plc

Simon Deacon, Chief Executive Officer

Jim Snooks, Chief Financial Officer

Andrew Hempsall, Chief Operating Officer

 

www.lightsciencetechnologiesholdings.com

via Walbrook PR

 

Shore Capital (Nominated Adviser and Broker)

Stephane Auton / George Payne

 

+44 (0)20 7408 4050

Walbrook PR Ltd (Media & Investor Relations)

Nick Rome / Marcus Ulker

Tel: +44 (0)20 7933 8780 or [email protected]

 

Notes to Editors:

 

About Light Science Technologies Holdings plc (www.lightsciencetechnologiesholdings.com)

 

Light Science Technologies Holdings plc ("LSTH") operates through three divisions: Passive fire protection ("PFP"); AgTech ("AGT") and contract electronics manufacturing ("CEM"). The Company is involved in the design, manufacturing, and installation of products and customized solutions spanning various industry sectors, with a focus on addressing global challenges related to food security, climate change, and fire protection, the Group is committed to developing robust solutions in these rapidly growing market sectors.

 

As both an installer and supplier of the fire resistant graphite barrier system Injectaclad, the PFP division is strongly positioned to capture a growing proportion of the fire remediation market as the Buildings Safety Regulator ("BSR") backlog unblocks, enabling accelerated conversion of the Company's strong sales pipeline. The Injectaclad system is a solution for the retrospective installation of cavity fire barriers in buildings using a pumped system, thereby avoiding the need for full-scale façade removal. It addresses a significant problem in the UK's built environment, where thousands of buildings require remediation to meet fire safety standards. For more information please visit Cavity Fire Barrier Remediation System | Injectaclad Ltd

 

The Group's tailored AgTech solutions encompass control systems, grow lights, sensor technology, venting, and irrigation systems, catering to both UK and global customers. Key markets include indoor, vertical, glasshouses, polytunnels, and more recently wider applications in broadacre farming. Driving factors comprise global food and water shortages, a growing population, government policies promoting sustainable growth methods, heightened scrutiny of food production's impact on climate change, and a shift away from processed foods. Key markets span Eastern Europe, the Americas, Australasia, and select locations in the Middle East, with the Company expanding routes to market via low-cost, low risk distribution agreements globally. For more information please visit: Sustainable grow lights and sensor technology - Light Science Technologies

 

The CEM division excels in designing, procuring, and manufacturing high-quality electronic products, with a specialisation in Printed Circuit Boards. These products find application across diverse sectors such as audio, automotive, electronics, gas detection, lighting, pest control, telecommunications and AgTech. For more information please visit: Home | UK Circuits

 

The Group is strongly positioned across a range of high growth sectors with proven technologies and solutions. It is increasingly focused on high margin opportunities that will drive cash generation. Furthermore, it is positioned for accelerated growth, targeting larger contracts and increasing recurring revenues - as both legislation and global issues look set to underpin demand for its products, driving the Company towards sustained profitable growth.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTDQLFBQELXBBD

Related Shares:

Light Science Technologies
FTSE 100 Latest
Value10,307.02
Change41.70